Cargando…

Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a cryptogenic chronic interstitial pneumonia with progressive fibrosis and a poor prognosis. A substantial number of epidemiological studies have been conducted in Europe and the United States (US). In contrast, in Japan, only one study reported the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondoh, Yasuhiro, Suda, Takafumi, Hongo, Yoshie, Yoshida, Manami, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Homma, Sakae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822670/ https://www.ncbi.nlm.nih.gov/pubmed/35135550 http://dx.doi.org/10.1186/s12931-022-01938-6

Ejemplares similares

Diagnosis and treatment of influenza based on health insurance claims between the 2010–2011 and 2019–2020 influenza seasons in Japan
por: Shimizu, Eiko, et al.
Publicado: (2022)

Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease
por: Yoshida, Manami, et al.
Publicado: (2021)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019)

Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data
por: Yoshida, Manami, et al.
Publicado: (2021)

Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis
por: Kawachi, Izumi, et al.
Publicado: (2022)

Opioid prescriptions at the point of surgery, bone metastasis, or death among patients with breast cancer in Japanese acute care hospitals: a claims-based, retrospective, longitudinal study
por: Yoshida, Manami, et al.
Publicado: (2023)

Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database
por: Ishida, Takayuki, et al.
Publicado: (2018)

Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database
por: Ogino, Mieko, et al.
Publicado: (2016)

Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan
por: Hosogaya, Naoki, et al.
Publicado: (2023)

Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses
por: Kurazono, Kenji, et al.
Publicado: (2022)

Analysis of antihypertensive treatment using real-world Japanese data—the retrospective study of antihypertensives for lowering blood pressure (REAL) study
por: Ohishi, Mitsuru, et al.
Publicado: (2019)

Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database
por: Ono, Yasuhisa, et al.
Publicado: (2020)

Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study
por: Nishimura, Rimei, et al.
Publicado: (2019)

Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study
por: Odawara, Masato, et al.
Publicado: (2021)

A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes
por: Nagai, Yoshio, et al.
Publicado: (2021)

Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
por: Ogura, Takashi, et al.
Publicado: (2023)

Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis
por: Nishimura, Rimei, et al.
Publicado: (2022)

A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data
por: Kawachi, Izumi, et al.
Publicado: (2022)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion
por: Fujisawa, Tomoyuki, et al.
Publicado: (2019)

1497. Epidemiology of RSV infection in Japan: A nationwide claims database analysis
por: Kobayashi, Yasuhiro, et al.
Publicado: (2020)

Epidemiology of respiratory syncytial virus in Japan: A nationwide claims database analysis
por: Kobayashi, Yasuhiro, et al.
Publicado: (2021)

Disease trends after Helicobacter pylori eradication based on Japanese nationwide claims and the health check-up database
por: Mizukami, Kazuhiro, et al.
Publicado: (2023)

Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data
por: Hiroi, Shinzo, et al.
Publicado: (2016)

Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database
por: Okuda, Shoki, et al.
Publicado: (2023)

End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
por: Akiyama, Norimichi, et al.
Publicado: (2022)

In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
por: Izumi, Chisato, et al.
Publicado: (2023)

Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data
por: Hiroi, Shinzo, et al.
Publicado: (2017)

The environmental impact of inhaler replacement: A carbon footprint and economic calculation of the National Database of Health Insurance Claims in Japan
por: Nagasaki, Kazuya, et al.
Publicado: (2023)

Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
por: Hamada, Shota, et al.
Publicado: (2015)

Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
por: Nakamura, Yutaro, et al.
Publicado: (2016)

Burden of Repeated Hospitalizations on Patients with Heart Failure: An Analysis of Administrative and Claims Data in Japan
por: Eguchi, Shunsuke, et al.
Publicado: (2022)

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Isshiki, Takuma, et al.
Publicado: (2019)

How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan
por: Watanabe, Tomone, et al.
Publicado: (2022)

Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in Japan
por: Murata, Tatsunori, et al.
Publicado: (2020)

Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database
por: Takagi, Akira, et al.
Publicado: (2022)

PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases
por: Kim, S.W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hehcp4k9jv90cgkt99m2kr1teo